GFP-Human Liver Carcinoma Cells (SNU423)
Quick Actions
Product Overview
Description
GFP-Human Liver Carcinoma Cells (SNU423) are a specialized line of human liver cancer cells that have been genetically engineered to continuously express green fluorescent protein (GFP). This innovative modification enables researchers to visualize these cells in real time, providing insights into various aspects of liver tumor biology.
Through fluorescence microscopy, scientists can observe the growth patterns, morphological characteristics, and migratory behavior of the carcinoma cells. Additionally, this technique allows for the detailed analysis of how the cells respond to different therapeutic treatments, making SNU423 cells an invaluable tool in cancer research and drug development.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBP-0128GFP
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characteristics:
Cell type: Human liver carcinoma / hepatocellular carcinoma cells
Marker: Stable GFP expression
Growth: Adherent
Morphology: Carcinoma-like epithelial/adherent cells; parental cultured cells reported as multinucleated
Tissue origin: Liver
Disease: Hepatocellular carcinoma
Quick Facts
Product Type
Tumor Cells
Viability
>98% viable (Trypan Blue exclusion)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
